University of Ulm

• NCT06421597

  Collaborator, Phase 2, Active, not recruiting, 36 people, 20 May 2024

• Ultra-high-caloric, Fatty Diet in ALS

  Active, not recruiting, 399 people, 28 Feb 2024

• NCT05753852

  Collaborator, Phase 3, Status unknown, 184 people, 3 Mar 2023

• NCT05099471

  Collaborator, Phase 2, Recruiting, 80 people, 29 Oct 2021

• Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

  Phase 3, Recruiting, 650 people, 13 Nov 2020

• NCT03800524

  Collaborator, Phase 3, Status unknown, 337 people, 11 Jan 2019

• NCT03620903

  Collaborator, Phase 2, Active, not recruiting, 53 people, 8 Aug 2018

• NCT02770378

  Phase 1/2, Completed, 10 people, 12 May 2016

• NCT02758665

  Phase 2, Completed, 41 people, 2 May 2016

• NCT02310243

  Phase 1/2, Status unknown, 50 people, 8 Dec 2014

• NCT02298166

  Phase 3, Terminated, 9 people, 21 Nov 2014

• NCT02013648

  Phase 3, Completed, 204 people, 17 Dec 2013

• NCT01914965

  Collaborator, Phase 2, Completed, 40 people, 2 Aug 2013

• NCT01788020

  Phase 3, Completed, 202 people, 11 Feb 2013

• NCT01427686

  Phase 4, Status unknown, 20 people, 1 Sept 2011

• NCT01237808

  Phase 3, Completed, 144 people, 10 Nov 2010

• NCT01180322

  Phase 2, Completed, 277 people, 12 Aug 2010

• NCT00893399

  Phase 3, Completed, 600 people, 6 May 2009

• NCT00850382

  Phase 1/2, Completed, 89 people, 25 Feb 2009

• NCT00710216

  Phase 4, Withdrawn, 40 people, 4 Jul 2008

Sources: clinicaltrials.gov

• Deutsche Forschungsgemeinschaft

  Sonderforschungsbereiche, Mechanismen der Alterung und Verjüngung hämatopoetischer Stammzellen des Menschen, 496370931, €219.9k, 2022, 1 Jan 2022

• Deutsche Forschungsgemeinschaft

  Sonderforschungsbereiche, SFB 1506: Alterung an Schnittstellen, 450627322, €3.1m, 2022, 1 Jan 2022

• Deutsche Forschungsgemeinschaft

  Sonderforschungsbereiche, Epigenetische Uhren, blutbasierte Biomarker und funktionelle Parameter zur Bestimmung des biologischen Alters, 496464827, €329.8k, 2022, 1 Jan 2022

• Deutsche Forschungsgemeinschaft

  Sonderforschungsbereiche, Die Schnittstelle von Regeneration und Alterung: Regeneration im Zebrafisch erfordert erweiterte AntiAgingMechanismen, 496463746, €109.9k, 2022, 1 Jan 2022

• Deutsche Forschungsgemeinschaft

  Sonderforschungsbereiche, Das Notch/NFKB Wechselspiel an der alternden Synapse: Die Rolle des Inflammaging beim kognitiven Verfall, 496369637, €219.9k, 2022, 1 Jan 2022

Sources: openalex.org

• Protocol to quantify cell-surface vimentin on senescent human chondrocytes and other cell types via a cell-based ELISA

  20 Mar 2026

• Targeting the CXCL12/CXCR4 pathway by an optimized derivative or EPI-X4 preserves chondrocyte function and offers a novel therapeutic approach in rheumatic diseases

  2 Dec 2025

• Comparing loss of individual fragile X proteins suggests strong links to cellular senescence and aging

  21 Oct 2025

• Co-Stimulatory and Immune Checkpoint Molecule Expression on Peripheral Immune Cells Differs Age Dependently Between Healthy Donors and Patients with Head and Neck Squamous Cell Carcinoma

  2 Oct 2025

Sources: api.crossref.org